GS-441524 is a nucleoside analog compound used in veterinary antiviral programs associated with feline infectious peritonitis (FIP). In clinical discussions related to feline health management, this compound is frequently mentioned as part of structured treatment approaches designed for cats diagnosed with FIP.
The product is provided as a 20mg/ml injectable formulation in an 8ml sterile vial. This configuration allows flexible dosage planning based on the body weight of the animal. Injectable administration is commonly selected because it provides stable absorption during long-term treatment protocols.
Manufactured in China, each vial is sealed and labeled to ensure product identification, storage safety, and traceability during distribution.
| Item | Specification |
|---|---|
| Product Name | GS-441524 Injection |
| CAS Number | 1191237-69-0 |
| Concentration | 20mg/ml |
| Dosage Form | Injectable Solution |
| Vial Size | 8ml per vial |
| Storage Condition | Room Temperature |
| Shelf Life | 1 Year from Date of Manufacture |
| Country of Manufacture | China |
| Function | Treatment for Cat FIP |
The product is packaged in sterile vials and labeled with batch number and expiration date.
Feline Infectious Peritonitis is a viral disease that develops from mutations of feline coronavirus within the host. Although many cats carry feline coronavirus without severe symptoms, certain mutations can lead to systemic infection.
The disease is commonly classified into several forms depending on its clinical presentation:
Wet (Effusive) FIP – accumulation of fluid in the abdomen or chest
Dry (Non-effusive) FIP – inflammation affecting internal organs
Ocular FIP – eye involvement such as inflammation or vision changes
Neurological FIP – infection affecting the nervous system
Because these forms may progress differently, treatment programs often adjust dosage based on the severity and type of the condition.
The dosage of GS-441524 injection is typically calculated according to body weight. Veterinary professionals may adjust treatment protocols depending on disease progression and clinical response.
| Condition | Reference Dosage |
|---|---|
| Wet FIP | 0.3 ml/kg body weight + 0.1 ml residue |
| Dry FIP | 0.4 ml/kg body weight + 0.1 ml residue |
| Eye / Nerve Involvement | 0.5 ml/kg body weight + 0.1 ml residue |
| Recurrence | 0.6 ml/kg body weight + 0.1 ml residue |
Body weight monitoring during treatment helps maintain consistent dosing throughout the treatment cycle.
The 20mg/ml 8ml GS-441524 injection is designed to support veterinary dosing flexibility and treatment planning.
Main characteristics include:
Standard 20mg/ml concentration suitable for common FIP protocols
8ml vial capacity allowing multi-day treatment cycles
Injectable formulation enabling systemic delivery
Clearly labeled packaging for identification and record tracking
Room temperature storage for convenient logistics
These features make the product practical for veterinary clinics, animal hospitals, and feline care organizations.
To ensure product stability and quality:
Store at room temperature in a dry environment
Protect from direct sunlight or excessive heat
Keep the vial sealed until administration
Follow sterile handling procedures during injection
When stored according to these guidelines, the product maintains stability for up to 12 months from the manufacturing date.
Each GS-441524 injection vial is packaged to support safe transportation and storage. The 8ml vial format is often selected by veterinary professionals because it offers a practical balance between dosage flexibility and packaging size.
The product is typically supplied to:
Veterinary clinics
Animal hospitals
Veterinary pharmaceutical distributors
Cat rescue and rehabilitation organizations
Secure export packaging can be arranged for international shipments.
This product is intended for veterinary use.
Treatment protocols and dosage decisions should be determined by qualified veterinary professionals according to the cat’s medical condition.
